Literature DB >> 20231914

Causal inference from longitudinal studies with baseline randomization.

Sengwee Toh, Miguel A Hernán.   

Abstract

We describe analytic approaches for study designs that, like large simple trials, can be better characterized as longitudinal studies with baseline randomization than as either a pure randomized experiment or a purely observational study. We (i) discuss the intention-to-treat effect as an effect measure for randomized studies, (ii) provide a formal definition of causal effect for longitudinal studies, (iii) describe several methods -- based on inverse probability weighting and g-estimation -- to estimate such effect, (iv) present an application of these methods to a naturalistic trial of antipsychotics on symptom severity of schizophrenia, and (v) discuss the relative advantages and disadvantages of each method.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20231914      PMCID: PMC2835458          DOI: 10.2202/1557-4679.1117

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  14 in total

1.  Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

Authors:  J M Robins; D M Finkelstein
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

2.  A structural approach to selection bias.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; James M Robins
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

3.  A definition of causal effect for epidemiological research.

Authors:  M A Hernán
Journal:  J Epidemiol Community Health       Date:  2004-04       Impact factor: 3.710

4.  Effect of acyclovir on herpetic ocular recurrence using a structural nested model.

Authors:  Stephen R Cole; Haitao Chu
Journal:  Contemp Clin Trials       Date:  2005-03-04       Impact factor: 2.226

Review 5.  Comparison of dynamic treatment regimes via inverse probability weighting.

Authors:  Miguel A Hernán; Emilie Lanoy; Dominique Costagliola; James M Robins
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-03       Impact factor: 4.080

6.  Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial.

Authors:  Sandra L Tunis; Douglas E Faries; Allen W Nyhuis; Bruce J Kinon; Haya Ascher-Svanum; Ralph Aquila
Journal:  Value Health       Date:  2006 Mar-Apr       Impact factor: 5.725

Review 7.  A method for the analysis of randomized trials with compliance information: an application to the Multiple Risk Factor Intervention Trial.

Authors:  S D Mark; J M Robins
Journal:  Control Clin Trials       Date:  1993-04

8.  Structural accelerated failure time models for survival analysis in studies with time-varying treatments.

Authors:  Miguel A Hernán; Stephen R Cole; Joseph Margolick; Mardge Cohen; James M Robins
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-07       Impact factor: 2.890

9.  Effects of body composition and leisure-time physical activity on transitions in physical functioning in the elderly.

Authors:  Thaddeus Haight; Ira Tager; Barbara Sternfeld; William Satariano; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2005-08-24       Impact factor: 4.897

10.  Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán; James M Robins; Kathryn Anastos; Joan Chmiel; Roger Detels; Carolyn Ervin; Joseph Feldman; Ruth Greenblatt; Lawrence Kingsley; Shenghan Lai; Mary Young; Mardge Cohen; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2003-10-01       Impact factor: 4.897

View more
  37 in total

1.  Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.

Authors:  Linda Barlow-Mosha; Konstantia Angelidou; Jane Lindsey; Moherndran Archary; Mark Cotton; Sylvia Dittmer; Lee Fairlie; Enid Kabugho; Portia Kamthunzi; Arti Kinikar; Tapiwa Mbengeranwa; Levina Msuya; Pauline Sambo; Kunjal Patel; Emily Barr; Patrick Jean-Phillipe; Avy Violari; Lynne Mofenson; Paul Palumbo; Benjamin H Chi
Journal:  Clin Infect Dis       Date:  2016-07-20       Impact factor: 9.079

2.  Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease.

Authors:  Goodarz Danaei; Luis A García Rodríguez; Oscar Fernández Cantero; Roger Logan; Miguel A Hernán
Journal:  Stat Methods Med Res       Date:  2011-10-19       Impact factor: 3.021

Review 3.  Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.

Authors:  Shibing Yang; Charles B Eaton; Juan Lu; Kate L Lapane
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-01-24       Impact factor: 2.890

4.  Surgery versus nonsurgical treatment of lumbar spinal stenosis: a randomized trial.

Authors:  Anthony Delitto; Sara R Piva; Charity G Moore; Julie M Fritz; Stephen R Wisniewski; Deborah A Josbeno; Mark Fye; William C Welch
Journal:  Ann Intern Med       Date:  2015-04-07       Impact factor: 25.391

5.  Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization.

Authors:  Sengwee Toh; Sonia Hernández-Díaz; Roger Logan; James M Robins; Miguel A Hernán
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

6.  Beyond the intention-to-treat in comparative effectiveness research.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz
Journal:  Clin Trials       Date:  2011-09-23       Impact factor: 2.486

7.  Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies.

Authors:  Mohammad Ehsanul Karim; John Petkau; Paul Gustafson; Robert W Platt; Helen Tremlett
Journal:  Stat Methods Med Res       Date:  2016-09-21       Impact factor: 3.021

8.  Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists.

Authors:  Mohammad Ali Mansournia; Julian P T Higgins; Jonathan A C Sterne; Miguel A Hernán
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

9.  Effects of analgesics on bone mineral density: A longitudinal analysis of the prospective SWAN cohort with three-group matching weights.

Authors:  Kazuki Yoshida; Zhi Yu; Gail A Greendale; Kristine Ruppert; Yinjuan Lian; Sara K Tedeschi; Tzu-Chieh Lin; Sebastien Haneuse; Robert J Glynn; Sonia Hernández-Díaz; Daniel H Solomon
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-12-12       Impact factor: 2.890

10.  Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.

Authors:  Øyvind Holme; Magnus Løberg; Mette Kalager; Michael Bretthauer; Miguel A Hernán; Eline Aas; Tor J Eide; Eva Skovlund; Jørn Schneede; Kjell Magne Tveit; Geir Hoff
Journal:  JAMA       Date:  2014-08-13       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.